Unlock the Potential of Your API with our oral excipients ... MORE

The highest load omega-3 powder ingredient in its class for dietary supplements ... MORE

Biodegradable material solutions to enhance the safety, biocompatibility and performance of medical implants ... MORE

As a CDMO expert we provide modern, established sites for LNP manufacturing and filling, as well as process technologies for CGMP manufacturing ... MORE

Evonik is a preferred CMO partner for APIs, HPAPIs and intermediates. Learn more about how our network, process expertise and upscaling capabilities support even the largest and most complex projects ... MORE

Dietary supplements that leverage our advanced health ingredients and oral dosage form expertise ... MORE

We are a Market Leader for Parenteral Excipients ... MORE

Our broad and flexible portfolio of drug delivery systems enables you to to optimize drug performance with superior targeting outcomes ... MORE

Our broad portfolio of parenteral drug delivery technologies, formulation development, manufacturing and filling services makes us your prefered CDMO for parenteral drug delivery. ... MORE

Proprietary surface modification technology to improve medical device safety and functionality ... MORE

EUDRACAP® leverages the functional versatility and safety of EUDRAGIT® to solve key challenges in oral drug delivery ... MORE

Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. PhytoSquene® is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. ... MORE

EUDRACAP® preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. ... MORE

Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology. ... MORE

The cooperation leverages the HPAPI competencies of both companies and provides customers with a fully integrated offering from the pre-clinical stage to commercial manufacturing. ... MORE

Evonik’s production site in Ham in northern France has reduced its direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions to zero. It is the first site from the Health Care business at Evonik to go carbon neutral. ... MORE

The dressing epicite® balance is particularly suited and optimized for the treatment of chronic wounds with low to medium exudation. ... MORE

Evonik now offers cQrex® KC, a performance-boosting peptide for cell culture media used in the manufacture of biological drugs. ... MORE

Evonik has entered into an agreement with specialty chemicals distributor Safic-Alcan to provide nutraceuticals to a wider customer base.  ... MORE

The company won the award for Best New Bioprocessing Supplier in Upstream Processing, in recognition of its high-quality cell culture solutions for pharmaceutical and biotech companies. ... MORE

In this interview, Eric Neuffer discusses the adoption of sustainable practices such as waste reduction, using renewable energy sources, adopting green energy principles, and investing in research and development of sustainable technologies. ... MORE

This article discusses the significance of formulation development, cGMP manufacturing and aseptic filling challenges, which must all be overcome before the potential of recent imporvements of humen genome can be fully commercialized. ... MORE

 In this article, Dr. Martin Schilling discusses how replacing L-Tyrosine with dipeptides can enhance the solubility for free L-Tyrosine at neutral pH.  ... MORE

In this interview with Dr. Jay Natarajan, one of Evonik’s formulation and manufacturing experts for LNPs and liposomes, some of these differences are reviewed. ... MORE

In this article, we explain why toxicological evaluation is important at every stage of HPAPI development and manufacturing and how experienced CDMOs ensure new life-saving treatments are brought to market safely. ... MORE

In this article, Dr. Martin Schilling talks through approaches to stabilize L-Glutamine against chemical degradation in cell culture media applications. ... MORE